INTERNATIONAL PATENT: CHILDREN'S NATIONAL MEDICAL CENTER FILES APPLICATION FOR "TRANSFORMING GROWTH FACTOR SS (TGF-SS) OLIGONUCLEOTIDE COMBINATION THERAPY FOR TREATING MUSCULOSKELETAL DISEASES"

GENEVA, April 30 -- CHILDREN'S NATIONAL MEDICAL CENTER (111 Michigan Avenue, N.W.Washington, DC 20010-2970) filed a patent application (PCT/US2024/051949) for "TRANSFORMING GROWTH FACTOR B (TGF-B) OLIGONUCLEOTIDE COMBINATION THERAPY FOR TREATING MUSCULOSKELETAL DISEASES" on Oct 18, 2024. With publication no. WO/2025/085731, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JAISWAL, Jyoti, K. (c/o Children's National Medical Center111 Michigan Avenue, N.W.Washington, DC 20010-2970), NOVAK, James, S. (c/o Children's National ...